<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/infex-therapeutics-phase-iia-resp-x-pseudomonas-bronchiectasis-ers-2026</loc>
    <lastmod>2026-09-08T13:43:29+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T00:00:00+05:30</news:publication_date>
      <news:title>Infex Therapeutics Reports Phase IIa Signal in Bronchiectasis</news:title>
      <news:keywords>Infex Therapeutics</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/58334c76-f1b4-4f02-a3c3-00b6b61c284c/0e3c3a61-1f31-43c4-8f01-74c6ce506fda.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/novartis-harbor-phase-iii-misses-primary-endpoint-dm1-del-desiran</loc>
    <lastmod>2026-09-08T13:43:44+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T00:00:00+05:30</news:publication_date>
      <news:title>Novartis HARBOR Phase III Trial Misses Primary Endpoint</news:title>
      <news:keywords>Novartis</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/58334c76-f1b4-4f02-a3c3-00b6b61c284c/b6b12a83-f0d2-4fe9-ae3e-d8f56db3bd26.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cormica-opens-medical-device-chemistry-lab-bradford-centre-of-excellence</loc>
    <lastmod>2026-09-08T13:43:47+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T00:00:00+05:30</news:publication_date>
      <news:title>Cormica Opens Medical Device Chemistry Lab in Bradford</news:title>
      <news:keywords>Cormica</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/09/cormica-bradford-medical-device-chemistry-laboratory-opening-600x600.jpg</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/hrv-pharma-rs-150-crore-synthetic-peptides-hpapi-oncology-expansion</loc>
    <lastmod>2026-09-08T13:43:34+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-08T00:00:00+05:30</news:publication_date>
      <news:title>HRV Pharma Commits Rs. 150 Crore to Build API Capacity</news:title>
      <news:keywords>HRV Pharma</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4e4f9cbb-caec-4513-9cd6-9a4df79b146b/cabe9bdc-0521-4789-b28c-d438dce85c43.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sanofi-tricog-ai-cardiac-diagnostics-partnership</loc>
    <lastmod>2026-09-07T21:53:56+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-07T00:00:00+05:30</news:publication_date>
      <news:title>Sanofi Signs Three-Year Partnership with Tricog to Scale AI Cardiac Diagnostics</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/6fda7795-f370-4941-9603-c242d6591139/fba99160-367d-4354-9a61-f374ae184c8a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/pfizer-discontinues-minipress-xl-global-manufacturing-cessation</loc>
    <lastmod>2026-09-07T21:52:22+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-07T00:00:00+05:30</news:publication_date>
      <news:title>Pfizer Discontinues Minipress XL Following Global Manufacturing Cessation Decision</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a428cdf2-985a-4d76-8c2b-28f494db96f3/0c9cd854-e0e3-4913-8f0c-1646618ca720.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/novo-nordisk-step-young-phase-3-pediatric-semaglutide-obesity</loc>
    <lastmod>2026-09-07T21:54:44+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-07T00:00:00+05:30</news:publication_date>
      <news:title>Novo Nordisk Achieves Primary Endpoint in STEP Young Phase 3 Trial for Pediatric Semaglutide Indication</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a428cdf2-985a-4d76-8c2b-28f494db96f3/d97c2a2d-72ea-4c4f-b149-5cb34fbc15cb.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-breast-cancer-serena-6</loc>
    <lastmod>2026-09-07T21:51:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-07T00:00:00+05:30</news:publication_date>
      <news:title>AstraZeneca Wins FDA Nod After SERENA-6 Cuts Progression Risk 56%</news:title>
      <news:keywords>AstraZeneca</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a428cdf2-985a-4d76-8c2b-28f494db96f3/343d4c26-ed3a-413a-a8d3-406cf5c32b7a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fosun-pharma-hk1-billion-h-share-buyback-gland-pharma-stake-disposal</loc>
    <lastmod>2026-09-07T11:07:28+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-07T00:00:00+05:30</news:publication_date>
      <news:title>Fosun Pharma Secures HK$1B H-Share Buyback via Gland Stake Sale</news:title>
      <news:keywords>Fosun Pharma</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/73c05041-e792-48a1-a87c-2a6549866623.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/indian-immunologicals-abhayrab-quality-dispute-cdsco-batch-records</loc>
    <lastmod>2026-09-07T11:07:07+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-07T00:00:00+05:30</news:publication_date>
      <news:title>Indian Immunologicals Disputes Abhayrab Findings, Submits Records</news:title>
      <news:keywords>Indian Immunologicals</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/6f0e8972-e93a-480e-8821-a8be9374f779.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/rezubio-fda-nmpa-ind-clearances-rz-520-chronic-respiratory-disease</loc>
    <lastmod>2026-09-07T11:07:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-07T00:00:00+05:30</news:publication_date>
      <news:title>Rezubio Gains FDA, NMPA IND Clearances for Inhaled RZ-520</news:title>
      <news:keywords>Rezubio</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/015acb19-2ccf-41f2-82c1-68f1b4208c91.png</image:loc>
    </image:image>
  </url>
</urlset>